Severe Doxycycline-Induced Oesophagitis With Granulomatous Inflammation Managed in a Rural Australian Hospital: A Case Report.

Case report OA: gold CC-BY-4.0
📄 Open PDF View on PubMed View at publisher

Abstract

Pill-induced oesophageal injury or pill oesophagitis typically presents with acute retrosternal pain, odynophagia, and dysphagia. While often self-limiting, cases may mimic acute coronary syndrome, food bolus, oesophageal perforation, and mediastinitis. Doxycycline is among the most commonly implicated medications. We report the case of a 32-year-old woman with severe mid-oesophageal ulceration secondary to doxycycline commenced for rosacea, managed at a rural Australian hospital. The histopathology finding of granulomatous inflammation was deemed reactive and secondary to severe ulceration, in the absence of infection or sarcoidosis. The patient was treated supportively with complete clinical and endoscopic resolution. Clinicians should consider pill oesophagitis in patients with acute retrosternal pain and odynophagia after starting doxycycline, and conservative management can be successful.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

SciLite annotations

chemicals 32
tetracyclines pamidronate potassium chloride ferrous ammonium sulfate hexahydrate doxycycline tetracycline doxycycline doxycycline doxycycline doxycycline doxycycline doxycycline doxycycline hyclate gelatin water water sucralfate doxycycline doxycycline doxycycline sucralfate water doxycycline alcohol doxycycline pantoprazole sucralfate pantoprazole doxycycline doxycycline doxycycline doxycycline
organisms 5
noordeloos 2009062 ammonia-oxidizing bacterium cytomegalovirus human alphaherpesvirus 1 strain rh2 human

Source provenance

europepmc
last seen: 2026-11-15T09:34:25.365398+00:00
scilite
last seen: 2026-11-15T10:16:09.319260+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Per Europe PMC